BAM
AGN

Bruderman Asset Management’s Allergan plc AGN Stock Holding History

Bruderman Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-365
Closed -$53K – 642
2019
Q1 		$53K Buy
365
+2
+0.6% +$290 0.01% 261
2018
Q4 		$49K Buy
+363
New +$59.5K 0.01% 245
2018
Q3 		– Sell
-105
Closed -$18K – 375
2018
Q2 		$18K Buy
+105
New +$16.9K ﹤0.01% 276

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bruderman Asset Management's AGN Position: Q2 2019 in Review

Bruderman Asset Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 365 shares — an estimated $53K sold.

Bruderman Asset Management first reported a position in AGN in Q2 2018 and held it in 3 quarters. The position peaked at $53K in Q1 2019. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Bruderman Asset Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 365 Allergan plc shares in Q2 2019, an estimated $53K.
  • Bruderman Asset Management first reported a position in Allergan plc in Q2 2018 and held it in 3 quarters.
  • Bruderman Asset Management's Allergan plc position peaked at $53K in Q1 2019.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.